Glycemic control and survival in peritoneal dialysis patients with diabetes: A 2-year nationwide cohort study

[1]  D. Schaubel,et al.  International Comparisons of Native Arteriovenous Fistula Patency and Time to Becoming Catheter-Free: Findings From the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  S. Nakai,et al.  Rate of the "burnt-out diabetes" phenomenon in patients on peritoneal dialysis. , 2018, Diabetes research and clinical practice.

[3]  T. Hasegawa,et al.  Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  Gang Liu,et al.  Clinical analysis of 215 consecutive cases with fever of unknown origin , 2018, Medicine.

[5]  S. Nakai,et al.  FP655EFFECTS OF DIALYZER MEMBRANE MATERIALS ON SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS: A 2-YEAR COHORT STUDY FROM THE ANNUAL SURVEY OF THE JAPANESE RENAL DATA REGISTRY , 2018 .

[6]  S. Nakai,et al.  Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis? , 2017, Diabetes research and clinical practice.

[7]  S. Nakai,et al.  High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry , 2017, American Journal of Nephrology.

[8]  D. Rodríguez-Sanz,et al.  Footwear used by older people and a history of hyperkeratotic lesions on the foot , 2017, Medicine.

[9]  K. Wakai,et al.  An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013) , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[10]  Chul-woo Yang,et al.  Glycemic Control and Mortality in Diabetic Patients Undergoing Dialysis Focusing on the Effects of Age and Dialysis Type: A Prospective Cohort Study in Korea , 2015, PloS one.

[11]  K. Kalantar-Zadeh,et al.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays , 2015, Nature Reviews Nephrology.

[12]  M. Abe,et al.  Best Practice for Diabetic Patients on Hemodialysis 2012 , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[13]  T. Uzu,et al.  Glycated Albumin Predicts the Risk of Mortality in Type 2 Diabetic Patients on Hemodialysis: Evaluation of a Target Level for Improving Survival , 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[14]  L. Tomlinson,et al.  Association Between Glycemia and Mortality in Diabetic Individuals on Renal Replacement Therapy in the U.K. , 2014, Diabetes Care.

[15]  R. Bilous,et al.  KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  Y. Hayashino,et al.  Impact of atherosclerosis on the relationship of glycemic control and mortality in diabetic patients on hemodialysis. , 2012, Clinical nephrology.

[17]  H. Morgenstern,et al.  Hemoglobin A1c Levels and Mortality in the Diabetic Hemodialysis Population , 2012, Diabetes Care.

[18]  B. Freedman.  A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death , 2012, Diabetes Care.

[19]  J. Bargman,et al.  Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus , 2012, International Urology and Nephrology.

[20]  K. Kalantar-Zadeh,et al.  Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes , 2012, Diabetes.

[21]  T. Yoo,et al.  Good Glycemic Control Is Associated with Better Survival in Diabetic Patients on Peritoneal Dialysis: A Prospective Observational Study , 2012, PloS one.

[22]  M. Rocco,et al.  Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[23]  K. Kalantar-Zadeh,et al.  Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin? , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[24]  K. Kalantar-Zadeh,et al.  Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[25]  Koichi Matsumoto,et al.  Glycated hemoglobin or glycated albumin for assessment of glycemic control in hemodialysis patients with diabetes? , 2008, Nature Clinical Practice Nephrology.

[26]  H. Makino,et al.  Glycated albumin levels predict long‐term survival in diabetic patients undergoing haemodialysis , 2008, Nephrology.

[27]  B. Freedman,et al.  Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. , 2008, Kidney international.

[28]  D. Naimark,et al.  Patient and technique survival of diabetics on peritoneal dialysis: one-center's experience and review of the literature. , 2008, Clinical nephrology.

[29]  F. Schmidt.  Meta-Analysis , 2008 .

[30]  M. Inaba,et al.  Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. , 2007, Journal of the American Society of Nephrology : JASN.

[31]  J. Minakuchi,et al.  Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). , 2006, The journal of medical investigation : JMI.

[32]  B. Lindholm,et al.  Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  Mai-Szu Wu,et al.  Pre-Dialysis Glycemic Control is An Independent Predictor of Mortality Intype Ii Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[34]  T. Nakao,et al.  Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. , 1998, Internal medicine.

[35]  Mai-Szu Wu,et al.  Predialysis Glycemic Control is An Independent Predictor of Clinical Outcome in Type Ii Diabetics on Continuous Ambula Tory Peritoneal Dialysis , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[36]  J. Canham,et al.  A matter of life or death. , 1985, Nursing times.

[37]  F. Kronenberg,et al.  Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  S. Nakai,et al.  An overview of regular dialysis treatment in Japan (As of December 31, 2012) , 2014 .

[39]  Raymond Vanholder,et al.  Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2012, Diabetes care.

[40]  T. Nakao,et al.  Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. , 2007, Internal medicine.